Abstract:Objective:To express p53 protein fused with RDP ,a new cell‐penetrating peptide ,by the pro‐karyotic expression system and determine the strength of its immunogenicity .Methods :The coding se‐quence of p53 was amplified by PCR using plasmid pET28a‐p53 as a template and cloned into the prokary‐otic expression vector pET28a‐RDP .The constructed recombinant plasmid pET28a‐RDP‐p53 was trans‐formed into E. coli Rosetta ,protein expression was induced with IPTG and the protein was purified .The expressed product was identified by SDS‐PAGE .Then Kunming mice were divided into 4 groups ,i. e. blank control group (constant volume of normal saline) and RDP‐p53 fusion protein high‐dose ,medium‐dose and low‐dose groups (4 mg/kg ,2 mg/kg and 1 mg/kg) and were immunized by peritoneal ,once 2 d , of which the sera were separated 30 d later and determined for IgG level by ELISA .Results :Both restric‐tion analysis and sequencing proved that p53 gene was successfully cloned into the expression vector pET28a‐RDP ;RDP‐p53 fusion protein was expressed in both supernatant and precipitation .ELISA results showed that compared with the control group ,IgG content of the low‐dose and medium‐dose groups didn't increase significantly (p>0.05) ,but that of the high‐dose group increased significantly (p<0.05) .Con‐clusion:RDP‐p53 fusion protein was successfully expressed and purified ,it had weak immunogenicity and the immunogenicity was related to the dosage of administration ,which might provide some valuable infor‐mation for the study of the pharmacological effect of RDP‐p53 fusion protein for inhibiting brain tumors .

Soluble Expression and Activity Analysis of Apoptin Fusion Protein

Construction of Apoptin Fusion Gene Prokaryotic Expression Vector and Its Soluble Expression

Soluble Expression of Recombinant Apoptin Fused with Mutant Cell-penetrating Peptide

Expression, Purification and Activity Detection in Vitro of Apoptin

Screening of High Expression Strain and Activity Assay of Apoptin Fusion Protein

Construction of a prokaryotic expression vector for Apoptin and expression in E.coli

Construction of Prokaryotic Secretory Expression Vector of TAT-Apoptin and Expression in E.coli

A Novel Recombinant Fusion Protein with Soluble PD-1 and TIM-3 Domains Effectively Binds to Cancer Cells

[Construction, Expression and Purification of a Mammalian Secretory Recombinant Fusion Protein Rpc].

Construction of a prokaryotie expression vector for apoptin and preparation of polyelonal antibody of apoptin

Prokaryotic Expression and Biological Activity of Poly-Arg Protein Transduction Domain-Apoptin Fusion Protein

[Construction of a Prokaryotic Expression Vector for Apoptin and Preparation of Polyclonal Antibody of Apoptin].

Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli.

High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.

Expression and Immunogenicity Analysis of p53 Protein Fused with a New Cell-Penetrating Peptide

Study on Construction and Expression of a Prokaryotic Vector for Expression of Apoptin

Preparation of TAT-apoptosis Protein and Its Antitumor Activity in vitro

[Expression of Modified Humanized Immunoapoptotic Protein and Its Specific Killing Effect on HER2-positive Tumor Cells].

Expression of the fusion protein of human soluble B lymphocyte stimulator and diphtheria toxin in E.coli and its biological activity

Construction of Eukaryotic Expression Vector of NT4-APOPTIN-HA2-TAT in Secretory Form and Its Effects on the Tumor Cells

Soluble Expression of TNF-Related Apoptosis-Inducing Ligand and Optimization of Its Purification Conditions